DoP lists options to rationalise drug trade margins for Niti Aayog

In a meeting held earlier this month with Niti Aayog, DoP also
suggested that trade margin on all formulations and dosages be capped
at 100%.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dop-lists-options-to-rationalise-drug-trade-margins-for-niti-aayog/articleshow/71344471.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online